
BPC-157 + TB-500 + Cartalax — deep joint recovery.
Pre-filled multidose pen containing 10mg BPC-157, 10mg TB-500 and 10mg Cartalax (30mg total) — deep cartilage and joint recovery in a single stack.
Adamantium is a Xenogenix pre-filled multidose pen combining BPC-157 and TB-500 with Cartalax, a cartilage-targeting peptide, for structural joint and connective-tissue repair.
BPC-157 and TB-500 drive angiogenesis and soft-tissue repair, while Cartalax supports chondrocyte activity and cartilage matrix integrity.
Follow guided dosing based on your joint-recovery plan.
Subcutaneous via the Xenogenix pre-filled pen. Rotate injection sites.
Refrigerate at 2–8 °C. Protect from light.
Most users report measurable changes within 2–4 weeks of consistent use. Full results typically emerge across an 8–12 week protocol.
Yes. Our compounds are designed to be modular. Pair with complementary stacks from Recovery, Longevity, or Metabolic collections — our specialists can recommend a structure.
Every batch ships with a Certificate of Analysis verifying purity above 99% from an independent ISO-accredited lab.
Unopened, temperature-intact vials may be returned within 14 days. Opened compounds are non-returnable for safety reasons.